What is targeted post-translational modification?
Post-translational modifications (PTMs) are chemical changes that occur after protein translation, such as phosphorylation, acetylation, ubiquitination, etc. These modifications not only determine the protein's activity, localization, and stability, but also deeply impact signaling pathways, cell differentiation, and disease processes. In proteomics, targeted PTM analysis refers to the precise, quantitative, and highly specific mass spectrometry detection of selected PTM types and sites. Unlike global discovery proteomics, targeted PTM analysis focuses on specific questions, such as whether a phosphorylation site of a kinase signal is truly activated, whether key acetylation sites change significantly after drug administration, or whether ubiquitination regulation of a pathway is disrupted. This problem-driven research approach is highly valuable for drug development, mechanism studies, and biomarker discovery.
1. Why is targeted analysis of post-translational modifications necessary?
1. The abundance of post-translational modifications is extremely low, often masked by overall protein signals.
Most PTMs have modification ratios typically below 5%, and even below 1%. If relying solely on conventional proteomics scanning modes, many key sites cannot be captured, or the quantitative errors are significant. Targeted methods (such as PRM, MRM, SureQuant, etc.) can significantly enhance detection sensitivity, enabling researchers to precisely observe dynamic changes in low-abundance modifications.
2. PTMs have high site specificity.
A protein may have dozens of modification sites, each with different functions. Through targeted post-translational modifications, researchers can achieve absolute or relative quantification of specific sites, providing high-confidence evidence for elucidating complex signaling pathways.
3. PTM pathways have direct value for drug development.
1. The effects of kinase inhibitors are often reflected in changes at phosphorylation sites.
2. Epigenetic drugs regulate acetylation or methylation states.
3. Immunoregulatory drugs often involve the ubiquitination-deubiquitination system.
Targeted PTM can serve as key supporting data for efficacy evaluation, mechanism validation, and companion diagnostic development.
2. Common technical routes for targeted post-translational modifications.
1. Enrichment strategies.
Due to the low abundance of PTMs, pre-treatment usually requires enrichment:
- Phosphorylation: TiO₂, IMAC, PolyMAC
- Acetylation: Antibody enrichment
- Ubiquitination: K-ε-GG (diGly) antibody capture
A high-quality enrichment process directly affects the reproducibility of targeted post-translational modification data.
2. Mass spectrometry technical routes.
Targeted PTM analysis typically employs two strategies:
（1）MRM（Multiple Reaction Monitoring）
- Highly sensitive methods based on QqQ
- Commonly used for clinical translation and absolute quantification.
- High repeatability, suitable for large-scale cohorts.
（2）PRM（Parallel Reaction Monitoring）
- High-resolution monitoring based on Orbitrap
- Provides richer fragment information and improves specificity.
- Especially suitable for quantifying low-abundance PTMs in complex samples.
（3）SureQuant / Internal Standard Triggering
- Using stable isotope-labeled peptides as triggers.
- Automatically enhances monitoring depth.
- Extremely effective for difficult-to-detect sites.
Different strategies apply to different research objectives: for precise and translatable data, MRM is more suitable; for exploratory and highly specific validation stages, PRM is a common choice.
3. Advantages of targeted post-translational modifications.
1. High data reliability, useful for mechanism research.
Targeted mode reduces data variability dependent on search engines, increases the likelihood of capturing true signals, and provides researchers with clear evidence chains.
2. Extremely high dynamic range.
Capable of simultaneously detecting high-abundance and extremely low-abundance modification sites, suitable for studying drug stimulation, time series, dose-response models, etc.
3. Enables absolute quantification.
Combining internal standard peptides can provide molecular-level absolute abundance information, which is difficult to achieve in traditional discovery modes.
4. Typical scenarios applicable for targeted post-translational modifications.
1. Phosphorylation pathway studies (such as MAPK, PI3K-Akt)
Can analyze the true degree of signaling pathway activation, rather than relying on indirect antibody judgments.
2. Drug target validation and efficacy evaluation.
Detecting changes in key modification sites after drug administration can be used to determine if the dose is effective.
3. Epigenetic regulation studies (such as acetylation, methylation)
Helps researchers understand the relationship between chromatin state changes and gene expression regulation.
4. Immunosignaling and ubiquitination studies.
Has significant importance in inflammation, autophagy, and tumor immunity.
5. How to conduct high-quality targeted post-translational modification projects?
In practical projects, successful targeted PTM analysis often requires:
- Reliable enrichment systems (antibody specificity, enrichment efficiency, background control)
- High-resolution mass spectrometry platforms and stable LC-MS systems.
- Precise Target Selection and Peptide Design
- Strict Quality Control System and Cross-Batch Stability Verification
These factors are indispensable. Due to the extremely high sensitivity and methodological stability required for targeting PTMs, many research teams choose to collaborate with professional teams that have established platforms.
Targeted post-translational modification (PTM) analysis allows us to observe the true state of protein modifications with high sensitivity, site specificity, and strong repeatability, providing irreplaceable data support for life sciences research and drug development. If you are conducting signal pathway analysis, studying drug mechanisms of action, or need high-precision verification of key PTMs, targeted PTM is one of the most reliable experimental strategies. If you need to design a suitable targeted PTM scheme for your project, Biotai Parker Biotechnology can provide professional experimental procedures and quantitative strategy support.
Biotai Parker Biotechnology--A Quality Service Provider for Bioproduct Characterization and Multi-Omics Mass Spectrometry Detection
Related Services:
How to order?
